Webinar - Accelerate Global Clinical Development with Asia-Pacific

On 24 November 2026, Derodes Partners and PSCC are hosting a 2-hour executive webinar on "Accelerate Global Clinical Development with Asia-Pacific (APAC)".

Clinical development is being redrawn. According to the IQVIA Institute (Global R&D Trends 2026), Western Europe is still the most-used region for clinical trials, but its share of trial country use has dropped 17% since 2019. Meanwhile, Asia-Pacific keeps gaining ground, and deals between China-based and international biopharma companies hit an all-time high in 2025.

For European biotechs, the question has shifted from whether to include APAC to how and when.

👉 Why integrate APAC into your clinical development plan?

 👉 How do you partner with the region?

We'll focus on oncology and bring together industry and academic views from the region:

• Pramod Kashid, CEO, Expecto Health Sciences (part of Southern Star Research), a CRO operating across Asia, Australia and New Zealand

• Dr Mitsumi Terada, MD, PhD, Section Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan

• Prof Ravindran Kanesvaran, Co-Director at Singapore Translational Cancer Consortium (STCC), Chairman, Division of Medical Oncology National Cancer Centre Singapore

📅 24 November 2026 | 10:00–12:00 CET / 17:00–19:00 SGT | Online